XML 32 R3.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Comprehensive Loss - CAD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
REVENUE      
Sales of goods $ 5,287,093 $ 5,550,432 $ 5,103,399
Provision of services 1,267,749 2,054,627 1,950,466
TOTAL REVENUE 6,554,842 7,605,059 7,053,865
COST OF SALES (4,490,728) (6,814,384) (4,410,777)
GROSS PROFIT 2,064,114 790,675 2,643,088
OPERATING EXPENSES      
Amortization 35,960 179,482 135,966
Depreciation 510,677 593,277 175,098
Director fees 600,933 522,349 370,094
Insurance 1,825,137 3,722,237 2,962,767
Office and miscellaneous 6,303,879 5,397,961 6,455,998
Professional fees 4,145,586 6,821,583 4,445,949
Research and development 1,554,823 651,302 510,895
Share-based payments 2,021,664 3,311,024 3,952,595
Travel 704,994 396,388 143,904
Wages and salaries 6,976,792 6,105,020 2,768,010
Total operating expenses (24,680,445) (27,700,623) (21,921,276)
OTHER INCOME (EXPENSE)      
Change in fair value of derivative liability 211,110 5,502,688 8,149,812
Finance and other costs 83,280 44,345 5,074
Foreign exchange gain (249,563) 745,102 362,448
Loss on disposal of assets (944) (10,755)
Loss on write-off of notes receivable (101,351) (309,385) (891,471)
Government income 5,232 2,446 24,148
Write down of deposit (228,572)
Loss on impairment of goodwill and intangibles (6,454,914) (4,579,763)
Other income (expense) (943,243) (35,371) 4,968
NET LOSS FOR THE YEAR (23,611,810) (27,654,364) (16,202,972)
Items that may be reclassified to profit or loss      
Foreign exchange translation (94,861) 447,542 136,475
Items that will not be reclassified to profit or loss      
Change in fair value of equity investments at FVOCI (3,180) (98,483) (332,640)
COMPREHENSIVE LOSS FOR THE YEAR $ (23,709,851) $ (27,305,305) $ (16,399,137)
Net Income (Loss) per share - Diluted $ 0.56 $ 0.82 $ 0.59
Net Income (Loss) per share - Diluted $ 0.56 $ 0.82 $ 0.59
Weighted average number of common shares outstanding - Basic 42,192,384 33,556,969 27,787,348
Weighted average number of common shares outstanding - Diluted 42,192,384 33,556,969 27,787,348